Intrathecal drug delivery systems for cancer pain and noncancer pain: OHTAC recommendation
Health Quality Ontario
Record ID 32016000557
English
Authors' recommendations:
OHTAC members acknowledged that some patients may benefit from intrathecal drug delivery systems. However, given the very low quality of evidence, OHTAC members felt that they could not support widespread adoption of the technology beyond the current status in Ontario. OHTAC members also felt that the evidence was not sufficiently conclusive to definitively recommend against public funding.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/eds/ohtas/recommendation-intrathecal-drug-delivery-systems-for-cancer-pain-and-noncancer-pain-en-1611.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Drug Delivery Systems
- Neoplasms
- Pain
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.